Stay updated on Safety, PK, and PD of FDL169 in CF - Clinical Trial
Sign up to get notified when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.

Latest updates to the Safety, PK, and PD of FDL169 in CF - Clinical Trial page
- Check3 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the old revision label was removed. The 'Back to Top' element was also removed, which is a minor UI change.SummaryDifference0.3%
- Check10 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.3%
- Check17 days agoChange DetectedThe web page has been updated to include a new facility name and location in Prague, Czechia, along with significant additions related to drug safety and cystic fibrosis treatments, while removing some redundant location terms and previous mentions of cystic fibrosis.SummaryDifference4%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Safety, PK, and PD of FDL169 in CF - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.